![cover image](https://wikiwandv2-19431.kxcdn.com/_next/image?url=https://upload.wikimedia.org/wikipedia/commons/thumb/6/6c/Benaroya_Research_Institute.jpg/640px-Benaroya_Research_Institute.jpg&w=640&q=50)
Benaroya Research Institute
From Wikipedia, the free encyclopedia
Benaroya Research Institute (BRI) is a Seattle, Washington, non-profit organization that conducts medical research on diseases and immune disorders, including autoimmune disease. It is affiliated with Virginia Mason Health System, and is located on the campus of Virginia Mason Medical Center.[2]
![]() | This article contains content that is written like an advertisement. (October 2019) |
Quick Facts Established, Research type ...
![]() | |
![]() | |
Established | 1956 |
---|---|
Research type | Basic (non-clinical), clinical and translational research |
Field of research | Immune system and autoimmune disease |
President | Jane H. Buckner, MD[1] |
Address | 1201 Ninth Avenue |
Location | Seattle, Washington |
Affiliations | Virginia Mason Health System[2] |
Website | www |
Close
Much of BRI's research aims to understand how immune cells function and why they malfunction to cause disease.[3][4] BRI researchers has studied on how immune cells contribute to rheumatoid arthritis, type 1 diabetes, multiple sclerosis, and other diseases.[3][4] BRI uses translational research and clinical trials.[4][5]